Item 7.01. Regulation FD Disclosure.
Soleno Therapeutics, Inc., a Delaware corporation (the "Company"), is furnishing
presentation materials included as Exhibit 99.1 to this report pursuant to Item
7.01 of Form 8-K. The Company is not undertaking to update this presentation.
The information in this report (including Exhibit 99.1) is being furnished
pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section. This report will not be deemed an
admission as to the materiality of any information herein (including Exhibit
99.1).
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
99.1 Presentation Materials
104 Cover Page Interactive Data File (formatted as inline XBRL and
contained in Exhibit 101).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses